The company in question is, MEDNAX, Inc. (NYSE:MD) currently with a stock price of 65.34 (-1.24% today). The market cap for MEDNAX, Inc. is 6263.37, and is in the sector Healthcare, and Specialized Health Services industry. The target price for MEDNAX, Inc. is 74. Currently MEDNAX, Inc. is trading with a P/E of 18.48, and a forward P/E of 14.44. Average volume for MEDNAX, Inc. is 602.86 and so far today it is 182055.
Performance in the last year for MEDNAX, Inc. has been -17.13%. For EPS growth, MEDNAX, Inc. has seen a growth of 12.70%, and is looking to grow in the next year to 10.60%. More long term stats show that EPS growth has been 10.90% over the last five years and could be 14.60% for the next five years. MEDNAX, Inc. has seen sales growth quarter over quarter at 14.10%, with EPS growth quarter over quarter at -1.10%. The 20-day simple moving average is -0.45%, with the 200-day simple moving average coming to -3.66%.
Since the IPO date for MEDNAX, Inc. on the 9/20/1995, MEDNAX, Inc. has seen performance year to date to be -7.68%. With MEDNAX, Inc. trading at 65.34, the dividend yield is *TBA, and the EPS is 3.58.
So could MEDNAX, Inc., be undervalued? Well as said before P/E is 18.48. The PEG is 1.27, P/S is 2.1 and the P/B is at 2.38. The P/cash is 100.21, with P/free cash flow at 17.43.
MEDNAX, Inc. ability to deal with debt shows that the current ratio is 1.7, and the quick ratio is 1.7. This is with long term debt/equity at 0.56, and total debt/equity at 0.56.
In terms of margins, MEDNAX, Inc. has a gross margin of 33.40%, an operating margin of 19.20% and a profit margin of 11.20%.Payout ratio for MEDNAX, Inc. is 0.00%. Return on assets come to 7.20% with return on investment coming to 9.50%.
Insider ownership for MEDNAX, Inc., is at 2.10% and institutional ownership comes to *TBA. Outstanding shares are at 94.67. While shares float is 91.65. The float short is currently 10.23%, and short ratio is 15.55.